Update your Find a Dermatologist profile, the Academy's directory that's visited by over 1 million people a year.
Learn about the Academy's efforts to refocus its brand on education, advocacy, member-centricity, and innovation.
Discover the wealth of educational opportunities offered through the Academy.
You and your peers will get together for hundreds of educational sessions covering the breadth of the specialty. Registration opens in November.
Find practical guidance on coding issues common in dermatology practices.
Learn how to avoid a penalty and earn an incentive when reporting MIPS.
Review current clinical guidelines, those in development, and guidelines that the AAD has collaborated on.
The Academy has developed 22 quality measures to help advance quality improvement.
Read this month's top stories in Dermatology World.
Check out DermWorld Insights & Inquiries for the latest updates from Dr. Warren Heymann
Access tools and practical guidance in evaluating and overcoming personal and staff burnout.
Get help to evaluate what practice model fits your needs, as well as guidance on selling a practice.
Learn about the Academy's advocacy priorities and how to join efforts to protect your practice.
Access resources to help you promote the specialty in your community and beyond.
Statement from AADA President Kenneth J. Tomecki, MD, FAAD
ROSEMONT, Ill. (June 1, 2021) — The American Academy of Dermatology Association strongly opposes recent efforts by state legislatures to restrict physicians’ ability to provide care to transgender youths. Legislation such as the bill enacted this spring in Arkansas as well as those proposed in several other states are a dangerous intrusion by government into medical decision-making.
The AADA recognizes the dignity and identity of transgender individuals and advocates for dermatologists’ ability to provide therapy and procedures that help the mental and physical well-being of these and all patients. Evidence has shown that transgender individuals who are forced to forgo gender-affirming care face an increased risk of mental health disorders including substance abuse disorders, and have higher rates of suicide.
Transgender and gender-diverse individuals can benefit greatly from medical and surgical gender-affirming treatments. These treatments are often medically necessary for the health and well-being of these patients and are not to be considered as cosmetic or elective.
Decisions about care should remain within the confines of the physician-patient relationship, guided by strong medical evidence and the best interests of the individual patient.